[Human parvovirus B19-induced aplastic crisis in a patient treated with fibrin sealant].
A 42-year-old woman underwent a myomectomy on March 31, 1998. On the 10th postoperative day, leukopenia and reticulocytopenia were observed. Bone marrow aspiration revealed severe erythroblastopenia with giant proerythroblasts, suggesting a recent parvovirus infection. Both anti-parvovirus B19 IgM antibody and IgG antibody seroconversion was observed, and human parvovirus B19 DNA was detected by polymerase chain reaction (PCR) methods. The hematologic data on the patient rapidly improved thereafter. It was determined that acute-phase serum had inhibited CFU-E and BFU-E derived colony formation. Based on these findings, parvovirus B19-induced aplastic crisis was diagnosed. Fibrin sealant, which is a typical hemostatic agent produced from blood, had been during the operation. Human parvovirus B19 DNA was detected in the fibrin sealant by PCR. Our case report documents the transmission of human parvovirus B19 by fibrin sealant.
Hino
M
M
Department of Clinical Hematology, Osaka City University Medical School.
Yamamura
R
R
Nishiki
S
S
Ohta
K
K
Yamane
T
T
Takubo
T
T
Tatsumi
N
N
D000208:Acute Disease; D000328:Adult; D016731:Erythema Infectiosum / Q000150:complications*; D005260:Female; D015718:Fibrin Tissue Adhesive / Q000009:adverse effects*; D006801:Humans; D007889:Leiomyoma / Q000601:surgery; D011183:Postoperative Complications; D012010:Red-Cell Aplasia, Pure / Q000209:etiology*; D014014:Tissue Adhesives / Q000009:adverse effects*; D014594:Uterine Neoplasms / Q000601:surgery
D015718:Fibrin Tissue Adhesive; D014014:Tissue Adhesives